This inventor holds 1 USPTO granted patent. Top assignee: Les Laboratoires Servier. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Louis-Philippe Beauregard: Innovator in Chemical Synthesis
Introduction
Louis-Philippe Beauregard is a notable inventor based in Québec, Canada. He has made significant contributions to the field of chemical synthesis, particularly in the development of innovative processes for producing complex compounds. His work has implications in various applications, showcasing the importance of his research in the pharmaceutical industry.
Latest Patents
Louis-Philippe holds a patent for a process related to the synthesis of piperazinyl-ethoxy-bromophenyl derivatives. This patent, titled "Process for the synthesis of piperazinyl-ethoxy-bromophenyl derivates and their application in the production of compounds containing them," highlights his expertise in industrial synthesis. The patent is a testament to his innovative approach and dedication to advancing chemical processes.
Career Highlights
Throughout his career, Louis-Philippe has been associated with Les Laboratoires Servier, a prominent company in the pharmaceutical sector. His role at the company has allowed him to apply his knowledge and skills in a practical setting, contributing to the development of new therapeutic compounds. His work has not only advanced the company's research but has also had a broader impact on the industry.
Collaborations
Louis-Philippe has collaborated with esteemed colleagues such as Christophe Hardouin and Martial Bertrand. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas. Working alongside talented individuals has enhanced his research and contributed to successful outcomes in their projects.
Conclusion
In summary, Louis-Philippe Beauregard is a distinguished inventor whose work in chemical synthesis has led to valuable advancements in the pharmaceutical industry. His patent and collaborations reflect his commitment to innovation and excellence in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
